Point-of-care testing speeds up diagnosis for deep vein thrombosis
Neal Aplin discusses how the introduction of point-of-care testing to Swindon's Great Western Hospital Ambulatory Care Unit eased pressure on staff, leading to improved patient flow and shorter waiting times. In addition, this has been the catalyst for the introduction of further POC testing in the hospital to support patient triage.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide...